Emcure Pharmaceuticals (NSE:EMCURE) Other Long-Term Liabilities : ₹4,756 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Other Long-Term Liabilities?

Emcure Pharmaceuticals's other long-term liabilities for the quarter that ended in Mar. 2025 was ₹4,756 Mil.

Emcure Pharmaceuticals's quarterly other long-term liabilities declined from Sep. 2024 (₹4,887 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹4,756 Mil).

Emcure Pharmaceuticals's annual other long-term liabilities increased from Mar. 2023 (₹1,047 Mil) to Mar. 2024 (₹2,118 Mil) and increased from Mar. 2024 (₹2,118 Mil) to Mar. 2025 (₹4,756 Mil).

Emcure Pharmaceuticals Other Long-Term Liabilities Historical Data

The historical data trend for Emcure Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Other Long-Term Liabilities Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Other Long-Term Liabilities

1,181.81

1,138.33

1,046.99

2,118.28

4,756.44

Emcure Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial				-	2,118.28	4,887.36	-	4,756.44

Emcure Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Emcure Pharmaceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

544210:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines